Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients "FORESPEAK-0"

Completed

Phase 2 Results

Summary of Purpose

Warfarin is very effective for the prevention of blood clots (thrombosis). A test of coagulation, the prothrombin time (PT) is used to monitor the effect. The PT response to warfarin can fluctuate as a result of interactions with a large number of other drugs, food or herbal agents as well as for no apparent reason. Thus, frequent monitoring of the PT and dose adjustments according to the results are required....

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 24 July 2012.

1 Jul 2006 23 Dec 2008 1 Jan 2009 1 Apr 2009 1 Jul 2012 7 Oct 2009
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions See All

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available